Navidea Biopharmaceuticals Inc (NAVBQ)

[DewDiligence]

>> …it is common sense that if a surgeon finds additional tumors there should be a survival benefit. <<

First of all, if medical practice were dictated solely by common sense, a lot of things might be different. We might not even need an FDA.

Second and more important, one could make a “common sense” argument that RIGS won’t be able to produce a material survival benefit, particularly in metastatic patients. I refer you to #msg-2482896 for additional color on why this might be the case.

In my humble opinion, your posts are sounding more and more like those of a patient advocate and less like those of an unemotional investor.